4 active not recruiting, 3 recruiting. 5 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 3, Recruiting 2 |
| Not applicable | 1 | Recruiting 1 |
Follow Computed Tomography with Contrast: new trials by email Literature Review of Computed Tomography with Contrast trials Research Report on Computed Tomography with Contrast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer Biospecimen Collection, Computed Tomography with Contrast, Electronic Health Record Review - Pancreatic Ductal Adenocarcinoma | Not applicable | Recruiting | Mayo Clinic | 100 | 2026-03-24 | 2026-10-14 |
| Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer Atezolizumab, Bevacizumab, Biopsy Procedure - Hereditary Leiomyomatosis and Renal Cell Carcinoma, Papillary Renal Cell Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 65 | 2022-06-10 | 2026-09-29 |
| Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents Biospecimen Collection, Cediranib Maleate, Computed Tomography - Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 120 | 2021-06-10 | 2026-10-22 |
| Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer Biospecimen Collection, Computed Tomography with Contrast, Magnetic Resonance Imaging - Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 46 | 2021-03-17 | 2026-09-10 |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study Computed Tomography with Contrast, Microwave Ablation, Questionnaire Administration - Lung Non-Small Cell Carcinoma, Metastatic Colorectal Carcinoma | Active not recruiting | M.D. Anderson Cancer Center | 74 | 2019-08-07 | 2026-10-07 | |
| Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 72 | 2018-07-20 | 2026-07-31 |
| Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change Biospecimen Collection, Computed Tomography with Contrast, Echocardiography Test - Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 46 | 2018-04-25 | 2026-10-22 |
Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Hereditary leiomyomatosis and renal cell cancer (1) · Lung Neoplasms (1) · Papillary renal cell carcinoma, sporadic (1) · Paraganglioma (1) · Pheochromocytoma (1) · Sarcoma (1) · Ureteral Neoplasms (1) · Urethral Neoplasms (1) · Urinary Bladder Neoplasms (1)
National Cancer Institute (NCI) (5) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (7) · Puerto Rico (1)
Ajit H. Goenka, MD (1) · Anishka A D'Souza (1) · Jaydira Del Rivero (1) · Jung-min Lee (1) · Ramaprasad Srinivasan (1) · Wayne L Hofstetter (1) · Zofia Piotrowska (1)
U10CA180820 (1), U10CA180821 (1), U10CA180868 (1), UM1CA186717 (1)